Ceftazidime - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for ceftazidime and what is the scope of freedom to operate?

Ceftazidime is the generic ingredient in ten branded drugs marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, Glaxosmithkline, Pai Holdings Pharm, Hospira, Lilly, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime. Three suppliers are listed for this compound.

Sponsor	Phase
Qianfoshan Hospital	N/A
Arrevus Inc.	Phase 2
King Faisal Specialist Hospital & Research Center	Phase 3

Sponsor

Phase

Qianfoshan Hospital

N/A

Arrevus Inc.

Phase 2

King Faisal Specialist Hospital & Research Center

Phase 3

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	TAZIDIME	ceftazidime	INJECTABLE;INJECTION	062655-002	Nov 20, 1985		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Glaxosmithkline	PENTACEF	ceftazidime	INJECTABLE;INJECTION	064008-002	Mar 31, 1992		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pai Holdings Pharm	FORTAZ IN PLASTIC CONTAINER	ceftazidime sodium	INJECTABLE;INJECTION	050634-001	Apr 28, 1989		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Glaxosmithkline	CEPTAZ	ceftazidime	INJECTABLE;INJECTION	050646-001	Sep 27, 1990		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pai Holdings Pharm	FORTAZ	ceftazidime	INJECTABLE;INJECTION	050578-003	Jul 19, 1985		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
B Braun	CEFTAZIDIME IN DEXTROSE CONTAINER	ceftazidime	INJECTABLE;INJECTION	050823-002	Jun 13, 2011		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	10
Applicants:	9
NDAs:	16
Drug Master File Entries:	17
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	67
Patent Applications:	7,320
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in ceftazidime?	ceftazidime excipients list
DailyMed Link:	ceftazidime at DailyMed